Instituto Nacional de Cancerología - Bogotá
Somos una institución del Estado colombiano en su orden nacional, que trabaja por el control integral del cáncer a través de la atención y el cuidado de pacientes, la investigación, la formación de talento humano y el desarrollo de acciones en salud públicaSelect an option
I am a doctor
I am a sponsor
Specializations
Cańcer
Our team
Medical staff
Osvaldo Sanchez
Laura Juliana Hernandez
Rosaura Bustamante
Fernando Contreras
Juan Alejandro Ospina
Felipe Fierro
Carlos Granados
Alexander Carreño
Open studies
Prostate cancer
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) - IDeate-Prostate01 - Merck Sharp & Dohme LLCSee more
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) - IDeate-Prostate01 - Merck Sharp & Dohme LLCSee more
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer - S1802 - Southwest Oncology GroupSee more
Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) - HERTHENA-Breast04 - Merck Sharp & Dohme LLCSee more
Cervical cancer
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) - TroFuse-036 - Merck Sharp & Dohme LLCSee more
Ovarian cancer
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) - TroFuse-022 - Merck Sharp & Dohme LLCSee more
Colorectal cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
